Associated Papers
Morpholino Antisense Oligomers as a Potential Therapeutic Option for the Correction of Alternative Splicing in PMD, SPG2, and HEMS.
Tantzer S et al.
Molecular Therapy. Nucleic Acids, 2018
Comprehensive genetic characteristics of dystrophinopathies in China.
Ma P et al.
Orphanet Journal of Rare Diseases, 2018
29973226 (PubMed )
Supplement: 13023_2018_853_MOESM1_ESM.pdf
Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan.
Okubo M et al.
Orphanet Journal of Rare Diseases, 2017
28859693 (PubMed )
Supplement: 13023_2017_703_MOESM1_ESM.pdf
MLPA-based genotype-phenotype analysis in 1053 Chinese patients with DMD/BMD.
Yang J et al.
Bmc Medical Genetics, 2013
Select a paper to view details